Publication at First Faculty of Medicine |
2007
Abstract
The effect of valproic acid (VA) on protein expression in human T-lymphocytic leukemia cells MOLT-4 was studied. VA is an inhibitor of histonedeacetylases and has a potential use as antitumor agent in leukemia treatment.
This study evaluates proteome changes after exposure to VA.